Approved drug products with therapeutic equivalence evaluations:33 edition
|
|
0
|
564
|
March 3, 2013
|
FDA update
|
|
0
|
703
|
March 2, 2013
|
Healthcare Compliance Packing council
|
|
0
|
447
|
March 2, 2013
|
FDA documents in 2013
|
|
0
|
714
|
February 26, 2013
|
COA Guide-IPEC 2013
|
|
1
|
721
|
February 23, 2013
|
Laboratory Data Integrity in FDA Warning Letters 2012
|
|
0
|
742
|
February 17, 2013
|
Good distribution practices for active substances for medicinal products for
|
|
0
|
484
|
February 17, 2013
|
WHO: Proposed GMP revisions Jan 2013
|
|
0
|
524
|
February 17, 2013
|
Ich: Q4b annex 13
|
|
0
|
790
|
February 17, 2013
|
Anvisa brazil : Water guide to pharmaceutical industry
|
|
0
|
565
|
February 17, 2013
|
Ich: Photosafety evaluation of pharmaceuticals
|
|
0
|
681
|
February 12, 2013
|
EU GMP revision
|
|
0
|
624
|
February 11, 2013
|
Indian Pharmacopoeia (IP): Guidance Manual for Compliance
|
|
0
|
891
|
January 7, 2013
|
New rules on importing API's into the EU
|
|
4
|
1035
|
December 14, 2012
|
Two-Week Grace Period for Generic Drug Facility Identification
|
|
0
|
575
|
December 5, 2012
|
Medical Devices : CDRH Fiscal Year 2013 (FY 2013) Proposed Guidance Development
|
|
0
|
425
|
December 4, 2012
|
SFDA Notification :Pharmaceutical Electronic Monitoring
|
|
0
|
553
|
November 28, 2012
|
EU: Incident management plan for medicines for human use
|
|
0
|
576
|
November 26, 2012
|
Black symbol: Identifying medicinal products for human use that are subject to
|
|
0
|
505
|
November 22, 2012
|
Guidance for IRBs, Clinical Investigators and Sponsors
|
|
0
|
601
|
November 22, 2012
|
Cdsco: Drug recall & rapid alert system for drugs-draft guidance
|
|
0
|
489
|
November 13, 2012
|
PIC/S update
|
|
0
|
598
|
November 11, 2012
|
Heparin : Change in Labeling Requirement by USP
|
|
0
|
516
|
November 10, 2012
|
Water for pharmaceutical use : Revised WHO Annex2
|
|
0
|
726
|
November 4, 2012
|
Latest : Who trs 970
|
|
0
|
1087
|
November 4, 2012
|
GUIDANCE FOR THE SETTING OF AOELs
|
|
0
|
630
|
October 31, 2012
|
Alternative Procedures Approved Under 21 CFR 640.120
|
|
0
|
611
|
October 30, 2012
|
Reference Manual for shipping Biological & Hazardous Materials
|
|
0
|
523
|
October 28, 2012
|
GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR BIOLOGICAL PRODUCTS: India
|
|
0
|
518
|
October 26, 2012
|
Clinical Trial Data Publishing Guidance: EMEA
|
|
0
|
771
|
October 23, 2012
|